Showing results (291-300 of 359) with videos related to
Sort By:
Pageof 36
Nature Cell Biology|March 30, 2024
Cyclophilin A supports translation of intrinsically disordered proteins and affects haematopoietic stem cell ageingLaure Maneix, Polina Iakova, Charles G Lee, et al.Nature|February 28, 2020
Lipid availability determines fate of skeletal progenitor cells via SOX9Nick van Gastel, Steve Stegen, Guy Eelen, et al.The Journal of Clinical Investigation|January 26, 2008
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in miceSiddhartha Mukherjee, Noopur Raje, Jesse A Schoonmaker, et al.Blood|September 10, 2014
Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioningBorja Saez, Francesca Ferraro, Rushdia Z Yusuf, et al.Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.Cell Metabolism|June 12, 2025
Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogrammingTing Zhao, Lingli He, Lai Ping Wong, et al.Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.Genome Medicine|January 28, 2024
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesionsShenglin Mei, Adele M Alchahin, Ioanna Tsea, et al.Nature|March 15, 2013
Differential stem- and progenitor-cell trafficking by prostaglandin E2Jonathan Hoggatt, Khalid S Mohammad, Pratibha Singh, et al.Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.Pageof 36